scispace - formally typeset
T

Thurayya Arayssi

Researcher at Cornell University

Publications -  80
Citations -  2134

Thurayya Arayssi is an academic researcher from Cornell University. The author has contributed to research in topics: Population & Behcet's disease. The author has an hindex of 21, co-authored 75 publications receiving 1539 citations. Previous affiliations of Thurayya Arayssi include American University of Beirut & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

TL;DR: In this article, the authors developed clinically relevant population, intervention, comparator, and outcomes (PICO) questions to develop updated guidelines for the pharmacologic management of rheumatoid arthritis.
Journal ArticleDOI

Integration of sequence data from a consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene

Yukinori Okada, +53 more
- 10 Feb 2014 - 
TL;DR: It is demonstrated that rare, low-frequency and common alleles at one gene locus, phospholipase B1 (PLB1), might contribute to risk of RA in a 4-generation consanguineous pedigree and also in unrelated individuals from the general population (European ancestry).
Journal ArticleDOI

Gastrointestinal Behçet's disease: a review.

TL;DR: Different classes of medications have been successfully used for the treatment of intestinal BD which include 5-aminosalicylic acid, corticosteroids, immunomodulators, and anti-tumor necrosis factor alpha monoclonal antibody therapy.
Journal ArticleDOI

Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects

TL;DR: C trachomatis appears to occasionally be disseminated to joints without producing overt disease, and there is some evidence of synovial reaction.
Journal ArticleDOI

Update on the therapy of Behçet disease.

TL;DR: Treatment of Behçet disease continues to be based largely on anecdotal case reports, case series, and a few randomized clinical trials.